US-based healthcare equipment provider Healthsense has secured $10m in financing on Tuesday in a round backed by pharmaceutical company Merck’s corporate venturing unit, Merck Global Health Innovation Fund.
Private equity firm Mansa Capital led the round, which also included venture capital firm Radius Ventures.
Healthsense provides remote monitoring equipment for senior healthcare. The capital will provide support for new ventures into managed care and other high-demand healthcare sectors.
Merck invested in a $7m series D round for Healthsense in 2012 that also featured Radius, Fallon Community Health Plan and West Health Investment fund.
The company has raised a total of $24.8m in funding.